Literature DB >> 17952562

Increased expression of hLRH-1 in human gastric cancer and its implication in tumorigenesis.

Shui-Liang Wang1, De-Zhu Zheng, Feng-Hua Lan, Xiao-Jun Deng, Jian Zeng, Cheng-Jin Li, Rong Wang, Zhong-Yong Zhu.   

Abstract

Altered signaling pathways or deregulated transcription factors represent an important category of molecular events leading to aberrant gene regulation in gastric cancer, among which the role of WNT/beta-catenin pathway remains unclear. LRH-1 is a critical transcription factor in controlling cell proliferation via crosstalk with the beta-catenin signaling pathway. In order to gain a knowledge of the expression of hLRH-1v1 and hLRH-1 in gastric cancer, a Q-PCR analysis was carried out. Our results showed that in about 50 and 47.6% of 42 tested patients with gastric cancer, the mRNA expression of hLRH-1v1 and hLRH-1 was significantly upregulated, as compared with self-paired normal control, respectively. Besides, overexpression of hLRH-1 was shown to promote the proliferation of gastric adenocarcinoma cell SGC-7901 via induction of cyclin E1. Taken together, our present study demonstrated for the first time the increased expression of hLRH-1v1 and hLRH-1 in human gastric cancer, an alteration which may implicate in tumorigenesis.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17952562     DOI: 10.1007/s11010-007-9616-1

Source DB:  PubMed          Journal:  Mol Cell Biochem        ISSN: 0300-8177            Impact factor:   3.396


  25 in total

Review 1.  The hallmarks of cancer.

Authors:  D Hanahan; R A Weinberg
Journal:  Cell       Date:  2000-01-07       Impact factor: 41.582

2.  Increased beta-catenin mRNA levels and mutational alterations of the APC and beta-catenin gene are present in intestinal-type gastric cancer.

Authors:  Matthias P A Ebert; Guo Fei; Sabine Kahmann; Oliver Müller; Jun Yu; Joseph J Y Sung; Peter Malfertheiner
Journal:  Carcinogenesis       Date:  2002-01       Impact factor: 4.944

3.  Beta-catenin regulates expression of cyclin D1 in colon carcinoma cells.

Authors:  O Tetsu; F McCormick
Journal:  Nature       Date:  1999-04-01       Impact factor: 49.962

4.  The metalloproteinase matrilysin is a target of beta-catenin transactivation in intestinal tumors.

Authors:  H C Crawford; B M Fingleton; L A Rudolph-Owen; K J Goss; B Rubinfeld; P Polakis; L M Matrisian
Journal:  Oncogene       Date:  1999-05-06       Impact factor: 9.867

5.  A regulatory cascade of the nuclear receptors FXR, SHP-1, and LRH-1 represses bile acid biosynthesis.

Authors:  B Goodwin; S A Jones; R R Price; M A Watson; D D McKee; L B Moore; C Galardi; J G Wilson; M C Lewis; M E Roth; P R Maloney; T M Willson; S A Kliewer
Journal:  Mol Cell       Date:  2000-09       Impact factor: 17.970

6.  Molecular basis for feedback regulation of bile acid synthesis by nuclear receptors.

Authors:  T T Lu; M Makishima; J J Repa; K Schoonjans; T A Kerr; J Auwerx; D J Mangelsdorf
Journal:  Mol Cell       Date:  2000-09       Impact factor: 17.970

7.  Identification of c-MYC as a target of the APC pathway.

Authors:  T C He; A B Sparks; C Rago; H Hermeking; L Zawel; L T da Costa; P J Morin; B Vogelstein; K W Kinzler
Journal:  Science       Date:  1998-09-04       Impact factor: 47.728

8.  Liver receptor homolog 1 controls the expression of the scavenger receptor class B type I.

Authors:  Kristina Schoonjans; Jean-Sebastien Annicotte; Thierry Huby; Oronza A Botrugno; Elisabeth Fayard; Yukihiko Ueda; John Chapman; Johan Auwerx
Journal:  EMBO Rep       Date:  2002-11-21       Impact factor: 8.807

Review 9.  WNT and beta-catenin signalling: diseases and therapies.

Authors:  Randall T Moon; Aimee D Kohn; Giancarlo V De Ferrari; Ajamete Kaykas
Journal:  Nat Rev Genet       Date:  2004-09       Impact factor: 53.242

10.  Genetic alterations in gastric adenomas of intestinal and foveolar phenotypes.

Authors:  Susan C Abraham; Seun Ja Park; Jae-Hyuk Lee; Lilian Mugartegui; Tsung-Teh Wu
Journal:  Mod Pathol       Date:  2003-08       Impact factor: 7.842

View more
  24 in total

1.  LRH1 as a driving factor in pancreatic cancer growth.

Authors:  Qiushi Lin; Arihiro Aihara; Waihong Chung; Yu Li; Zheping Huang; Xuesong Chen; Shaofan Weng; Rolf I Carlson; Jack R Wands; Xiaoqun Dong
Journal:  Cancer Lett       Date:  2013-12-11       Impact factor: 8.679

2.  LRH-1 controls proliferation in breast tumor cells by regulating CDKN1A gene expression.

Authors:  S Bianco; M Jangal; D Garneau; N Gévry
Journal:  Oncogene       Date:  2014-12-01       Impact factor: 9.867

3.  Effect of NR5A2 inhibition on pancreatic cancer stem cell (CSC) properties and epithelial-mesenchymal transition (EMT) markers.

Authors:  Zhaofan Luo; Yanan Li; Mingxin Zuo; Chang Liu; Weihua Tian; Dong Yan; Huamin Wang; Donghui Li
Journal:  Mol Carcinog       Date:  2017-01-12       Impact factor: 4.784

4.  Silencing LRH-1 in colon cancer cell lines impairs proliferation and alters gene expression programs.

Authors:  James R Bayrer; Sridevi Mukkamala; Elena P Sablin; Paul Webb; Robert J Fletterick
Journal:  Proc Natl Acad Sci U S A       Date:  2015-02-09       Impact factor: 11.205

Review 5.  Liver receptor homolog-1 (LRH-1): a potential therapeutic target for cancer.

Authors:  Christina Nadolny; Xiaoqun Dong
Journal:  Cancer Biol Ther       Date:  2015-05-07       Impact factor: 4.742

6.  Small molecule agonists of the orphan nuclear receptors steroidogenic factor-1 (SF-1, NR5A1) and liver receptor homologue-1 (LRH-1, NR5A2).

Authors:  Richard J Whitby; Jozef Stec; Raymond D Blind; Sally Dixon; Lisa M Leesnitzer; Lisa A Orband-Miller; Shawn P Williams; Timothy M Willson; Robert Xu; William J Zuercher; Fang Cai; Holly A Ingraham
Journal:  J Med Chem       Date:  2011-03-10       Impact factor: 7.446

7.  Down-regulation of miR-31 expression in gastric cancer tissues and its clinical significance.

Authors:  Yuanyuan Zhang; Junming Guo; Dong Li; Bingxiu Xiao; Ying Miao; Zhen Jiang; Hui Zhuo
Journal:  Med Oncol       Date:  2009-07-14       Impact factor: 3.064

Review 8.  Phospholipid--driven gene regulation.

Authors:  Paul M Musille; Jeffrey A Kohn; Eric A Ortlund
Journal:  FEBS Lett       Date:  2013-01-16       Impact factor: 4.124

9.  Structure-based discovery of antagonists of nuclear receptor LRH-1.

Authors:  Cindy Benod; Jens Carlsson; Rubatharshini Uthayaruban; Peter Hwang; John J Irwin; Allison K Doak; Brian K Shoichet; Elena P Sablin; Robert J Fletterick
Journal:  J Biol Chem       Date:  2013-05-10       Impact factor: 5.157

10.  The orphan nuclear receptor LRH-1 and ERα activate GREB1 expression to induce breast cancer cell proliferation.

Authors:  Ashwini L Chand; Dhilushi D Wijayakumara; Kevin C Knower; Kerrie A Herridge; Tamara L Howard; Kyren A Lazarus; Colin D Clyne
Journal:  PLoS One       Date:  2012-02-16       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.